The key role of AMPK in sensing energy status has led to significant interest in AMPK as a therapeutic target for dysfunctional metabolism in type 2 diabetes, insulin resistance and obesity. This evidence concerns the gene PRKAB1 and obesity due to melanocortin 4 receptor deficiency.